Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 17661

1.

The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.

Sevigny J, Chiao P, Bussière T, Weinreb PH, Williams L, Maier M, Dunstan R, Salloway S, Chen T, Ling Y, O'Gorman J, Qian F, Arastu M, Li M, Chollate S, Brennan MS, Quintero-Monzon O, Scannevin RH, Arnold HM, Engber T, Rhodes K, Ferrero J, Hang Y, Mikulskis A, Grimm J, Hock C, Nitsch RM, Sandrock A.

Nature. 2016 Aug 31;537(7618):50-6. doi: 10.1038/nature19323.

PMID:
27582220
2.

How neuroinflammation contributes to neurodegeneration.

Ransohoff RM.

Science. 2016 Aug 19;353(6301):777-83. doi: 10.1126/science.aag2590. Review.

PMID:
27540165
3.

Cholinesterase Inhibitors and Behavioral & Psychological Symptoms of Alzheimer's Disease.

Graipaspong N, Thaipisuttikul P, Vallipakorn SA.

J Med Assoc Thai. 2016 Apr;99(4):433-40.

PMID:
27396229
4.

New data on harmful effects of trans-fatty acids.

Ginter E, Simko V.

Bratisl Lek Listy. 2016;117(5):251-3. Review.

PMID:
27215959
5.

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease.

Lebrec J, Ascher-Svanum H, Chen YF, Reed C, Kahle-Wrobleski K, Hake AM, Raskin J, Naderali E, Schuster D, Heine RJ, Kendall DM.

BMC Geriatr. 2016 May 3;16:93. doi: 10.1186/s12877-016-0264-8.

6.

Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.

Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M.

Nature. 2016 May 5;533(7601):125-9. doi: 10.1038/nature17664.

PMID:
27120160
7.

Cardiometabolic risk factors predict cerebrovascular health in older adults: results from the Brain in Motion study.

Tyndall AV, Argourd L, Sajobi TT, Davenport MH, Forbes SC, Gill SJ, Parboosingh JS, Anderson TJ, Wilson BJ, Smith EE, Hogan DB, Hill MD, Poulin MJ.

Physiol Rep. 2016 Apr;4(8). pii: e12733. doi: 10.14814/phy2.12733.

8.

Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Jaeger PA, Lucin KM, Britschgi M, Vardarajan B, Huang RP, Kirby ED, Abbey R, Boeve BF, Boxer AL, Farrer LA, Finch N, Graff-Radford NR, Head E, Hoffree M, Huang R, Johns H, Karydas A, Knopman DS, Loboda A, Masliah E, Narasimhan R, Petersen RC, Podtelezhnikov A, Pradhan S, Rademakers R, Sun CH, Younkin SG, Miller BL, Ideker T, Wyss-Coray T.

Mol Neurodegener. 2016 Apr 26;11:31. doi: 10.1186/s13024-016-0095-2. Erratum in: Mol Neurodegener. 2016;11(1):42.

9.

Untangling the brain's neuroinflammatory and neurodegenerative transcriptional responses.

Srinivasan K, Friedman BA, Larson JL, Lauffer BE, Goldstein LD, Appling LL, Borneo J, Poon C, Ho T, Cai F, Steiner P, van der Brug MP, Modrusan Z, Kaminker JS, Hansen DV.

Nat Commun. 2016 Apr 21;7:11295. doi: 10.1038/ncomms11295.

10.

Intra-Individual Variability of Physical Activity in Older Adults With and Without Mild Alzheimer's Disease.

Watts A, Walters RW, Hoffman L, Templin J.

PLoS One. 2016 Apr 20;11(4):e0153898. doi: 10.1371/journal.pone.0153898.

11.

Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.

Schmidt-Richberg A, Ledig C, Guerrero R, Molina-Abril H, Frangi A, Rueckert D; Alzheimer’s Disease Neuroimaging Initiative..

PLoS One. 2016 Apr 20;11(4):e0153040. doi: 10.1371/journal.pone.0153040.

12.

Poor self-rated health did not increase risk of permanent nursing placement or mortality in people with mild Alzheimer's disease.

Nielsen AB, Siersma V, Waldemar G, Waldorff FB.

BMC Geriatr. 2016 Apr 19;16:87. doi: 10.1186/s12877-016-0262-x.

13.

Discovering EEG resting state alterations of semantic dementia.

Grieder M, Koenig T, Kinoshita T, Utsunomiya K, Wahlund LO, Dierks T, Nishida K.

Clin Neurophysiol. 2016 May;127(5):2175-81. doi: 10.1016/j.clinph.2016.01.025.

PMID:
27072087
14.

Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.

Sung HY, Choi BO, Jeong JH, Kong KA, Hwang J, Ahn JH.

PLoS One. 2016 Apr 8;11(4):e0153156. doi: 10.1371/journal.pone.0153156.

15.

Exploring psychosocial interventions for people with dementia that enhance personhood and relate to legacy- an integrative review.

Johnston B, Narayanasamy M.

BMC Geriatr. 2016 Apr 5;16:77. doi: 10.1186/s12877-016-0250-1. Review.

16.

New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics.

Lutz MW, Crenshaw D, Welsh-Bohmer KA, Burns DK, Roses AD.

Curr Neurol Neurosci Rep. 2016 May;16(5):48. doi: 10.1007/s11910-016-0643-8. Review.

PMID:
27039903
17.

GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans.

Chittoor G, Kent JW Jr, Almeida M, Puppala S, Farook VS, Cole SA, Haack K, Göring HH, MacCluer JW, Curran JE, Carless MA, Johnson MP, Moses EK, Almasy L, Mahaney MC, Lehman DM, Duggirala R, Comuzzie AG, Blangero J, Voruganti VS.

BMC Genomics. 2016 Apr 2;17:276. doi: 10.1186/s12864-016-2594-5.

18.

GAMDB: a web resource to connect microRNAs with autophagy in gerontology.

Zhang L, Xie T, Tian M, Li J, Song S, Ouyang L, Liu B, Cai H.

Cell Prolif. 2016 Apr;49(2):246-51. doi: 10.1111/cpr.12247.

PMID:
27037912
19.

Effects of Exercise on Cognition: The Finnish Alzheimer Disease Exercise Trial: A Randomized, Controlled Trial.

Öhman H, Savikko N, Strandberg TE, Kautiainen H, Raivio MM, Laakkonen ML, Tilvis R, Pitkälä KH.

J Am Geriatr Soc. 2016 Apr;64(4):731-8. doi: 10.1111/jgs.14059.

PMID:
27037872
20.

An evolutionary roadmap to the microtubule-associated protein MAP Tau.

Sündermann F, Fernandez MP, Morgan RO.

BMC Genomics. 2016 Mar 31;17:264. doi: 10.1186/s12864-016-2590-9.

Items per page

Supplemental Content

Loading ...
Support Center